Skip to main content
Fig. 3 | Allergy, Asthma & Clinical Immunology

Fig. 3

From: The impact of CFTR modulator triple therapy on type 2 inflammatory response in patients with cystic fibrosis

Fig. 3

Association between ETI = Elexacaftor/Tezacaftor/Ivacaftor initiation and log AEC = Absolute Eosinophil Count, with 95% confidence intervals computed from the multivariable mixed-effect model. The p-value denotes the significance of change in mean log AEC after starting ETI. Each point represents one observation, and patients can contribute multiple observations. Circles represent observations from female patients, while triangles represent observations from male patients

Back to article page